VIR - Vir BiotechnologyEPS of -$1.45 revenue of $3.8M misses by $18.59M
2023-08-03 16:09:55 ET
- Vir Biotechnology press release ( NASDAQ: VIR ): Q2 EPS of -$1.45 may not be comparable to consensus of -$1.19.
- Revenue of $3.8M misses by $18.59M .
- $1.9 billion in cash, cash equivalents and investments as of June 30, 2023
For further details see:
Vir BiotechnologyEPS of -$1.45, revenue of $3.8M misses by $18.59M